Want to join the conversation?
$PCAR 2Q15 Q&A: Ted of Susquehanna questioned if there are any biggest concerns for PCAR going forward, to which Ron said the company has a great team that delivers great results. It is always challenges, always opportunities, and PCAR looks forward to seizing and taking advantage of those moving forward, he added.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.